A Study to Compare Two Different Formulations of Mirikizumab in Healthy Participants

NCT04548219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Mirikizumab

Sponsor

Eli Lilly and Company